<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two new strategies for increasing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> uptake have been investigated </plain></SENT>
<SENT sid="1" pm="."><plain>First the effect of interleukin-2 (IL-2) on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> uptake of 125I-Lym-1 antibody in <z:mp ids='MP_0003815'>nude</z:mp> mice was investigated </plain></SENT>
<SENT sid="2" pm="."><plain>Secondly, the use of 67Cu-labeled Lym-1 was evaluated in patients </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mp ids='MP_0003815'>nude</z:mp> mice implanted with Raji human <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, a greater than 2-fold enhancement of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> uptake of 125I-Lym-1 was observed after administration of <z:chebi fb="77" ids="46793">PEG</z:chebi>-interleukin-2 (<z:chebi fb="77" ids="46793">PEG</z:chebi>-IL-2) </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="0" ids="51026">macrocycle</z:chebi> 1,4,8,11-tetraazacylcotetradecane-N,N',N",N"'-tetraacetic acid (TETA), synthesized specifically for copper chelation, has been conjugated to Lym-1 for 67Cu labeling of the monoclonal antibody (MoAb) </plain></SENT>
<SENT sid="5" pm="."><plain>There was no evidence for bone or <z:mpath ids='MPATH_458'>normal</z:mpath> marrow uptake and the residence time in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was prolonged </plain></SENT>
<SENT sid="6" pm="."><plain>Surprisingly, a dose of 4.4 mCi that was intended for imaging induced substantial <z:mp ids='MP_0010537'>tumor regression</z:mp> in a patient </plain></SENT>
</text></document>